- Nov 17, 2006
Why Johnson & Johnson Will Be a Bigger Winner With Boosters Than Pfizer and Moderna
It's looking like COVID-19 boosters will go three-for-three in winning authorizations. An advisory committee to the U.S. Food and Drug Administration (FDA) voted unanimously last week in support of boosters for Moderna's (NASDAQ: MRNA) COVID-19 vaccine and for Johnson & Johnson's (NYSE: JNJ)...
- An FDA panel recommended J&J vaccine boosters without restrictions imposed on mRNA vaccines.
Keith Speights, The Motley Fool